Display Settings:

Format

Send to:

Choose Destination
    Nat Rev Microbiol. 2007 Jul;5(7):540-53.

    Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

    Source

    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. mlevine@medicine.umaryland.edu

    Abstract

    More than 50 years of research has yielded numerous Shigella vaccine candidates that have exemplified both the promise of vaccine-induced prevention of shigellosis and the impediments to developing a safe and effective vaccine for widespread use, a goal that has yet to be attained. This Review discusses the most advanced strategies for Shigella vaccine development, the immune responses that are elicited following disease or vaccination, the factors that have accelerated or impeded Shigella vaccine development and our ideas for the way forward.

    PMID:
    17558427
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk